Legend Biotech CorporationLEGNNASDAQ
Loading
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 69.12% |
| Q2 2025 | -23.64% |
| Q1 2025 | -492.86% |
| Q4 2024 | 120.59% |
| Q3 2024 | -582.73% |
| Q2 2024 | 69.82% |
| Q1 2024 | 58.75% |
| Q4 2023 | -135.29% |
| Q3 2023 | 70.18% |
| Q2 2023 | -67.65% |
| Q1 2023 | 20.00% |
| Q4 2022 | -57.41% |
| Q3 2022 | 56.80% |
| Q2 2022 | -362.96% |
| Q1 2022 | 55.00% |
| Q4 2021 | 31.03% |
| Q3 2021 | -31.82% |
| Q2 2021 | -8.20% |
| Q1 2021 | -38.64% |
| Q4 2020 | 12.00% |
| Q3 2020 | 60.00% |
| Q2 2020 | -267.65% |
| Q1 2020 | 46.88% |
| Q4 2019 | -128.57% |
| Q3 2019 | 3.45% |
| Q2 2019 | -141.67% |
| Q1 2019 | 0.00% |